Cargando…

High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: a phase I study in progressive hormone refractory prostate cancer metastatic to bone

We tested the feasibility and toxicity of high activities Rhenium-186 hydroxyethylidene diphosphonate, with peripheral blood stem cell rescue in patients with progressive hormone refractory prostate cancer metastatic to bone. Twenty-five patients received between 2500 and 5000 MBq of Rhenium-186 hyd...

Descripción completa

Detalles Bibliográficos
Autores principales:	O'Sullivan, J M, McCready, V R, Flux, G, Norman, A R, Buffa, F M, Chittenden, S, Guy, M, Pomeroy, K, Cook, G, Gadd, J, Treleaven, J, Al-Deen, A, Horwich, A, Huddart, R A, Dearnaley, D P
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2002
Materias:	Clinical
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375418/ https://www.ncbi.nlm.nih.gov/pubmed/12087455 http://dx.doi.org/10.1038/sj.bjc.6600348

Ejemplares similares

Phase I/II trials of (186)Re-HEDP in metastatic castration-resistant prostate cancer: post-hoc analysis of the impact of administered activity and dosimetry on survival
por: Denis-Bacelar, Ana M., et al.
Publicado: (2016)

Therapeutic efficiency of rhenium-188-HEDP in human prostate cancer skeletal metastases
por: Liepe, K, et al.
Publicado: (2003)

Rhenium-188 Hydroxyethane 1,1-Diphosphonic Acid (HEDP) for Bone Pain Palliation Using BARC-HEDP Kits versus Pars-HEDP Kits: A Comparison on Preparation and Performance Aspects at Hospital Radiopharmacy
por: Ramakurup, Radhakrishnan Edathuruthy Kalarickal, et al.
Publicado: (2018)

Bone lesion absorbed dose profiles in patients with metastatic prostate cancer treated with molecular radiotherapy
por: Denis-Bacelar, Ana M, et al.
Publicado: (2018)

A radiobiological model of metastatic burden reduction for molecular radiotherapy: application to patients with bone metastases
por: Denis-Bacelar, Ana M, et al.
Publicado: (2017)

LMD-14. Preclinical safety and activity of intraventricular Rhenium-186 Nanoliposome ((186)RNL) for leptomeningeal metastases
por: Guerra-Garcia, Maria, et al.
Publicado: (2021)

Advanced high resolution x-ray diagnostic for HEDP experiments
por: Faenov, A. Y., et al.
Publicado: (2018)

Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects
por: Dearnaley, D P, et al.
Publicado: (2005)

LMD-13. ReSPECT-LM: Maximum tolerated dose, safety, and efficacy of intraventricular Rhenium-186 Nanoliposome ((186)RNL) for leptomeningeal metastases
por: Brenner, Andrew, et al.
Publicado: (2021)

(188)Re-HEDP therapy in the therapy of painful bone metastases
por: Liepe, Knut
Publicado: (2018)

LOCL-04 SAFETY AND FEASIBILITY OF RHENIUM-186 NANOLIPOSOME (186RNL) IN LEPTOMENINGEAL METASTASES [LM] PHASE 1/2A DOSE ESCALATION TRIAL
por: Brenner, Andrew, et al.
Publicado: (2022)

The utility of tumour markers in assessing the response to chemotherapy in advanced bladder cancer
por: Cook, A M, et al.
Publicado: (2000)

Pre-treatment nomogram for biochemical control after neoadjuvant androgen deprivation and radical radiotherapy for clinically localised prostate cancer
por: Parker, C C, et al.
Publicado: (2002)

Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma
por: Horwich, A, et al.
Publicado: (2014)

TIPS-23 SAFETY AND FEASIBILITY RESULTS FROM A PHASE 1/2 CLINICAL TRIAL OF RHENIUM (186RE) OBISBEMEDA (186RNL) IN RECURRENT GLIOMA: THE RESPECT-GBM TRIAL
por: Brenner, Andrew, et al.
Publicado: (2023)

Technetium-99m HMPAO and SPECT in the assessment of blood flow in human lung tumours.
por: Rowell, N. P., et al.
Publicado: (1989)

LMAP-21 PRELIMINARY CLINICAL DATA IN THE PHASE 1/2A DOSE ESCALATION TRIAL OF RHENIUM (186RE) OBISBEMEDA (186RNL) IN LEPTOMENINGEAL METASTASES (LM): THE RESPECT-LM TRIAL
por: Youssef, Michael, et al.
Publicado: (2023)

Rhenium‐186‐mercaptoacetyltriglycine‐labeled Monoclonal Antibody for Radioimmunotherapy: In vitro Assessment, in vivo Kinetics and Dosimetry in Tumor‐bearing Nude Mice
por: Kinuya, Seigo, et al.
Publicado: (1998)

Fertility, gonadal and sexual function in survivors of testicular cancer
por: Huddart, R A, et al.
Publicado: (2005)

Rhenium-Imido Corroles
por: Alemayehu, Abraham B., et al.
Publicado: (2020)

Randomised pilot study of dose escalation using conformal radiotherapy in prostate cancer: long-term follow-up
por: Creak, A, et al.
Publicado: (2013)

Evidence-based pragmatic guidelines for the follow-up of testicular cancer: optimising the detection of relapse
por: van As, N J, et al.
Publicado: (2008)

Ambient aging of rhenium filaments used in thermal ionization mass spectrometry: Growth of oxo-rhenium crystallites and anti-aging strategies
por: Mannion, Joseph M., et al.
Publicado: (2017)

Re-HEDP : pharmacokinetic characterization, clinical and dosimetric evaluation in osseous metastatic patients with two levels of radiopharmaceutical dose
por: Savio, Eduardo, et al.
Publicado: (2001)

Microsatellite instability in human testicular germ cell tumours.
por: Huddart, R. A., et al.
Publicado: (1995)

Efficacy of EDTA and HEDP Chelators in the Removal of Mature Biofilm of Enterococcus faecalis by PUI and XPF File Activation
por: Álvarez-Sagües, Alejandro, et al.
Publicado: (2021)

TIPS-22 A TWO-PART, PHASE 1 STUDY OF RHENIUM (186RE) OBISBEMEDA (186RNL) DELIVERED BY CONVECTION ENHANCED DELIVERY (CED) FOR RECURRENT, REFRACTORY, OR PROGRESSIVE CHILDHOOD EPENDYMOMA AND HIGH-GRADE GLIOMA (HGG)
por: Plant, Ashley, et al.
Publicado: (2023)

Peracetic acid application as an antimicrobial and its residual (HEDP): a holistic approach on the technological characteristics of chicken meat
por: de Rezende, Heloísa Carneiro, et al.
Publicado: (2023)

Decay studies of the long-lived states in $^{186}$Tl
por: Stryjczyk, M., et al.
Publicado: (2020)

Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder
por: Hafeez, S, et al.
Publicado: (2015)

Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder
por: Hafeez, S, et al.
Publicado: (2016)

Interaction of stopped antiprotons with nuclei (PS186)
por: Kanert, W, et al.
Publicado: (1985)

Molecular cytogenetic analysis of adult testicular germ cell tumours and identification of regions of consensus copy number change.
por: Summersgill, B., et al.
Publicado: (1998)

Europium(III) Meets Etidronic Acid (HEDP): A Coordination Study Combining Spectroscopic, Spectrometric, and Quantum Chemical Methods
por: Heller, Anne, et al.
Publicado: (2023)

Circulating lymphoma cells in patients with B & T non-Hodgkin's lymphoma detected by immunoglobulin and T-cell receptor gene rearrangement.
por: Brada, M., et al.
Publicado: (1987)

Combined in-beam electron and gamma-ray spectroscopy of (184,186)Hg
por: Scheck, M, et al.
Publicado: (2011)

(188)Re-HEDP combined with capecitabine in hormone-refractory prostate cancer patients with bone metastases: a phase I safety and toxicity study
por: Lam, Marnix G. E. H., et al.
Publicado: (2009)

Dynamic Processes of Rhenium Polyhydride Complexes
por: Naik, Datta V., et al.
Publicado: (2022)

EPCT-18. A TWO-PART, PHASE 1 STUDY OF RHENIUM-186 NANOLIPOSOME (186RNL) DELIVERED BY CONVECTION ENHANCED DELIVERY FOR RECURRENT, REFRACTORY, OR PROGRESSIVE EPENDYMOMA AND HIGH-GRADE GLIOMA (HGG) AND NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
por: Plant, Ashley, et al.
Publicado: (2021)

An In Situ XAS Study of the Cobalt Rhenium Catalyst for Ammonia Synthesis
por: Mathisen, Karina, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3ummh0ntiml5b9uk8ui42vank2